Friday, 2 October 2026Updated 7m ago
← Top stories
Deal● Neutral for Indian equities

Big Pharma turns to China for new drugs as patent cliff drives multibillion-dollar deals

1 source · first seen 16:48 2 Oct · updated 16:48 2 Oct

The brief

Written from 1 report · check the source before you trade
  • Western biopharma companies are increasingly turning to China to source drug innovation
  • The shift comes as pharma's patent cliff draws closer

Tags on this story

Pick a tag to see all its stories
Pharma and healthcare14 todayChina26 today

Linked by the tag Pharma and healthcare

173 stories this week
  1. 2 OctHospital stocks: can strong demand offset regulatory risks?Legal · 1 source · Supreme Court scrutiny of medicine mark-ups has raised concerns over hospital margins
  2. 1 OctSEBI clears Carlsberg India, TMC Transformers, Ujin Pharma and Matangi Rubber IPOsIPO · 3 sources · SEBI approved IPOs for Carlsberg India, TMC Transformers, Ujin Pharma and Matangi Rubber
  3. 1 OctWhy the stock market fell for 8th straight week, its longest losing streak in 25 yearsMarket move · 1 source · The market logged its eighth straight weekly decline, the longest losing streak in 25 years
  4. 1 OctHospital stocks extend losses as drug-pricing regulation concerns linger; Apollo, Max among top Nifty losersMarket move · 1 source
  5. 1 OctHospital stocks sell-off a buying opportunity or a risk? Here is what analysts adviceMarket move · 1 source · The Supreme Court flagged a case where drugs costing 2,700 to retailers were billed at 27,000 to patients
All Pharma and healthcare stories →

Read the reports

1 report · earliest 16:48
CNBCBig Pharma turns to China for new drugs as patent cliff drives multibillion-dollar deals16:48